Gentrepid statistics

To access cutting-edge analytics on consensus tools, life science contexts and associated fields, you will need to subscribe to our premium service.


Citations per year

Citations chart

Popular tool citations

chevron_left SNP prioritization chevron_right
Popular tools chart

Tool usage distribution map

Tool usage distribution map

Associated diseases

Associated diseases

Gentrepid specifications


Unique identifier OMICS_18228
Name Gentrepid
Interface Web user interface
Restrictions to use None
Computer skills Basic
Version 2.0
Stability Stable
Maintained Yes


  • person_outline Merridee Wouters <>

Additional information

Tuto:; A registration is needed to access to tools.

Publications for Gentrepid

Gentrepid in publications

PMCID: 4460746
PMID: 26044129
DOI: 10.1186/1755-8794-8-S2-S1

[…] identify novel therapeutics suitable for repositioning towards treatment of cad., previously, we were able to predict 264 candidate genes and 104 potential therapeutic targets for cad using gentrepid (, a candidate gene prediction platform with two bioinformatic modules to reanalyze wellcome trust case-control consortium gwas data. in an expanded study, using […]

PMCID: 4101352
PMID: 25077696
DOI: 10.1186/1755-8794-7-S1-S8

[…] phenotypes which may benefit from current therapeutics. such a drug repositioning tool can save valuable time and money spent on preclinical studies and phase i clinical trials., we previously used gentrepid ( as a platform to predict 1,497 candidate genes for the seven complex diseases considered in the wellcome trust case-control consortium genome-wide association […]

To access a full list of publications, you will need to upgrade to our premium service.

Gentrepid institution(s)
Structural and Computational Biology Division, Victor Chang Cardiac Research Institute, Darlinghurst, NSW, Australia; School of Computer Science and Engineering, University of New South Wales, Kensington, NSW, Australia; Centre for Molecular and Biomolecular Informatics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands; School of Medical Sciences, University of New South Wales, Kensington, NSW, Australia; Molecular Cardiology and Biophysics Division, Victor Chang Cardiac Research Institute, Darlinghurst, NSW, Australia; Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia; School of Life and Environmental Sciences, Deakin University, Geelong, VIC, Australia
Gentrepid funding source(s)
Supported by the St. Vincent’s Clinic Foundation; an NHMRC R. D. Wright Fellowship; the Australian National Health and Medical Research Council [grant number 635512]; the Ronald Geoffrey Arnott Fund; and an Australian Postgraduate Award through the University of New South Wales.

Gentrepid reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review Gentrepid